Total Payments
$7,551
2024 Payments
$1,209
Companies
35
Transactions
383
Medicare Patients
9,800
Medicare Billing
$674,560
Payment Breakdown by Category
Food & Beverage$7,452 (98.7%)
Education$99.46 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,452 | 366 | 98.7% |
| Education | $99.46 | 17 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,316 | 58 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $729.75 | 24 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $676.74 | 37 | $0 (2024) |
| Janssen Biotech, Inc. | $662.39 | 30 | $0 (2024) |
| PFIZER INC. | $579.92 | 43 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $550.06 | 29 | $0 (2024) |
| Lilly USA, LLC | $472.68 | 25 | $0 (2024) |
| TARO PHARMACEUTICALS USA, INC. | $302.18 | 26 | $0 (2019) |
| Amgen Inc. | $263.09 | 12 | $0 (2023) |
| Incyte Corporation | $261.50 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,209 | 48 | ABBVIE INC. ($267.59) |
| 2023 | $1,139 | 42 | ABBVIE INC. ($277.55) |
| 2022 | $1,018 | 49 | ABBVIE INC. ($328.16) |
| 2021 | $974.16 | 54 | AbbVie Inc. ($187.38) |
| 2020 | $458.70 | 25 | PFIZER INC. ($72.77) |
| 2019 | $1,063 | 54 | Sun Pharmaceutical Industries Inc. ($211.99) |
| 2018 | $837.24 | 65 | Taro Pharmaceuticals USA, Inc. ($238.93) |
| 2017 | $851.81 | 46 | Amgen Inc. ($109.94) |
All Payment Transactions
383 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.99 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.79 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/22/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.97 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: Immunology | ||||||
| 10/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.75 | General |
| Category: Immunology | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.47 | General |
| Category: Dermatology | ||||||
| 09/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: Immunology | ||||||
| 08/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.08 | General |
| Category: Dermatology | ||||||
| 08/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Immunology | ||||||
| 07/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Immunology | ||||||
| 07/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Immunology | ||||||
| 07/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: Immunology | ||||||
| 06/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Dermatology | ||||||
| 06/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: Dermatology | ||||||
| 06/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,448 | 4,780 | $388,290 | $174,067 |
| 2022 | 20 | 2,258 | 4,399 | $359,436 | $162,819 |
| 2021 | 21 | 2,442 | 4,872 | $388,621 | $174,885 |
| 2020 | 22 | 2,652 | 4,847 | $392,016 | $162,788 |
Total Patients
9,800
Total Services
18,898
Medicare Billing
$674,560
Procedure Codes
83
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 564 | 724 | $68,056 | $43,859 | 64.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 409 | 548 | $49,320 | $19,694 | 39.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 256 | 304 | $53,200 | $19,025 | 35.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 179 | 197 | $34,475 | $15,765 | 45.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 43 | 51 | $19,788 | $11,625 | 58.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 70 | 90 | $21,060 | $11,311 | 53.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 337 | 2,173 | $52,152 | $10,687 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 94 | $13,630 | $8,435 | 61.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 137 | 154 | $10,780 | $5,449 | 50.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 34 | 36 | $11,880 | $4,616 | 38.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 49 | 51 | $9,180 | $4,536 | 49.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 82 | 111 | $8,880 | $4,365 | 49.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $7,200 | $4,016 | 55.8% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 23 | 23 | $7,084 | $3,005 | 42.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 21 | $7,203 | $2,094 | 29.1% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 24 | $5,232 | $1,682 | 32.2% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 21 | 21 | $3,276 | $1,585 | 48.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 26 | 41 | $2,788 | $1,524 | 54.7% |
| 69100 | Biopsy of ear | Office | 2023 | 14 | 14 | $2,576 | $748.50 | 29.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 26 | 53 | $530.00 | $43.67 | 8.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 540 | 719 | $67,586 | $43,133 | 63.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 230 | 283 | $49,525 | $19,969 | 40.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 388 | 527 | $47,430 | $19,203 | 40.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 164 | 180 | $31,500 | $13,042 | 41.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 315 | 1,920 | $46,080 | $9,905 | 21.5% |
About Dr. Maria Pico, M.D
Dr. Maria Pico, M.D is a Specialist healthcare provider based in Stockbridge, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326044744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maria Pico, M.D has received a total of $7,551 in payments from pharmaceutical and medical device companies, with $1,209 received in 2024. These payments were reported across 383 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($7,452).
As a Medicare-enrolled provider, Pico has provided services to 9,800 Medicare beneficiaries, totaling 18,898 services with total Medicare billing of $674,560. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Stockbridge, GA
- Active Since 06/21/2005
- Last Updated 03/01/2010
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1326044744
Products in Payments
- SKYRIZI (Biological) $793.27
- DUPIXENT (Biological) $671.13
- EUCRISA (Drug) $562.71
- TREMFYA (Drug) $553.89
- TALTZ (Drug) $421.10
- COSENTYX (Biological) $310.22
- OPZELURA (Drug) $261.50
- Enbrel (Biological) $210.36
- RINVOQ (Biological) $204.61
- ILUMYA (Biological) $200.62
- TOPICORT (desoximetasone) Topical Spray, 0.25% (Drug) $177.56
- Humira (Biological) $165.77
- LIBTAYO (Biological) $162.65
- Winlevi (Drug) $147.21
- Otezla (Drug) $127.65
- HUMIRA (Biological) $124.25
- ENSTILAR (Drug) $121.48
- Finacea (Drug) $113.99
- DAXXIFY (Drug) $101.49
- SOOLANTRA (Drug) $94.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Stockbridge
Dr. Ronald Watts, M.d., F.a.c.e, M.D., F.A.C.E
Specialist — Payments: $129,877
Specialist $129,877
Neville Pereyo, M.d, M.D
Specialist — Payments: $13,319
Specialist $13,319
Nathan Lipsett, Md, MD
Specialist — Payments: $9,631
Specialist $9,631
Dr. Mary Taylor, M.d, M.D
Specialist — Payments: $6,992
Specialist $6,992
Dr. Mark Kozinn, M.d, M.D
Specialist — Payments: $6,608
Specialist $6,608
Dr. Andre' Holmes, M.d, M.D
Specialist — Payments: $6,408
Specialist $6,408